James Roach
James Roach is an experienced NHS director having held roles in hospitals, clinical commissioning groups and in joint roles with social care. James runs Conclusio Limited, developing innovative solutions in health and care systems in UK and China.
Latest articles
Reducing time to market for new COVID-19 vaccines
With the target set to offer a COVID-19 vaccine to a further 17.7 million people in the next five priority groups - including all...
NHS gives women Human Papillomavirus Virus (HPV) home testing kits
NHS England has announced that more than 31,000 women will be offered kits to carry out HPV self-sampling in the privacy and convenience of...
Tribunal upholds CMA decision on pharma collusion and £1.2m fine
The Competition Appeal Tribunal has upheld the Competition and Markets Authority (CMA)’s finding that pharmaceutical firm Lexon broke competition law, dismissing Lexon’s appeal. Last year,...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
NHS prescription charge to increase from 1 April 2021
The NHS prescription charge will increase to £9.35 per prescription item from 1 April 2021 in England, according to the Pharmaceutical Services Negotiating Committee...
NHS gives women Human Papillomavirus Virus (HPV) home testing kits
NHS England has announced that more than 31,000 women will be offered kits to carry out HPV self-sampling in the privacy and convenience of...
Nasal spray to protect against COVID-19 is ready for use in humans
A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...